| 000 | 01538 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513235540.0 | ||
| 264 | 0 | _c20010809 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a1055-9965 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShen, H | |
| 245 | 0 | 0 |
_aPolymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. _h[electronic resource] |
| 260 |
_bCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _cApr 2001 |
||
| 300 |
_a397-401 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aDiet |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFolic Acid _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMethylenetetrahydrofolate Reductase (NADPH2) |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aOxidoreductases Acting on CH-NH Group Donors _xgenetics |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aSpitz, M R | |
| 700 | 1 | _aWang, L E | |
| 700 | 1 | _aHong, W K | |
| 700 | 1 | _aWei, Q | |
| 773 | 0 |
_tCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _gvol. 10 _gno. 4 _gp. 397-401 |
|
| 999 |
_c11253367 _d11253367 |
||